| RS267607134 |
TOR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 1, torsion |
| RS267607135 |
TPRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 79, Hearing loss |
| RS267607136 |
TRAPPC9
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 13 |
| RS267607137 |
TRAPPC9
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal recessive 13 |
| RS267607138 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS267607140 |
TRPM1
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1C, Congenital stationary night blindness 1C |
| RS267607141 |
TRPM1
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1C, Congenital stationary night blindness 1C |
| RS267607142 |
TRPM4
|
Health Risk |
Likely pathogenic |
Progressive familial heart block type IB, TRPM4-related disorder |
| RS267607143 |
TRPV4
|
Health Risk |
Pathogenic |
Scapuloperoneal spinal muscular atrophy, Charcot-Marie-Tooth disease axonal type 2C |
| RS267607144 |
TRPV4
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronopathy, distal hereditary motor |
| RS267607145 |
TRPV4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2C, Scapuloperoneal spinal muscular atrophy |
| RS267607146 |
TRPV4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2C, Scapuloperoneal spinal muscular atrophy |
| RS267607147 |
TRPV4
|
Health Risk |
Pathogenic |
Metatropic dysplasia, Metatropic dysplasia |
| RS267607148 |
TRPV4
|
Health Risk |
Pathogenic |
Spondylometaphyseal dysplasia, Kozlowski type |
| RS267607149 |
TRPV4
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Maroteaux type |
| RS267607150 |
TRPV4
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Maroteaux type |
| RS267607152 |
TSPAN12
|
Health Risk |
Likely pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS267607153 |
TSPAN12
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS267607154 |
TSPAN12
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS267607155 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Primary dilated cardiomyopathy |
| RS267607156 |
TTN
|
Health Risk |
Likely pathogenic |
Tibial muscular dystrophy, Dilated cardiomyopathy 1G |
| RS267607158 |
TTN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS267607159 |
TTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyloidosis, hereditary systemic 1 |
| RS267607160 |
TTR
|
Health Risk |
Pathogenic |
Amyloidosis, hereditary systemic 1 |
| RS267607161 |
TTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyloidosis, hereditary systemic 1 |
| RS267607162 |
TUBB3
|
Health Risk |
Pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS267607163 |
TUBB3
|
Health Risk |
Pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS267607164 |
TUBB3
|
Health Risk |
Pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS267607165 |
TUBB3
|
Health Risk |
Pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS267607167 |
VANGL2
|
Health Risk |
risk factor |
Neural tube defects, susceptibility to |
| RS267607168 |
VANGL2
|
Health Risk |
risk factor |
Neural tube defects, susceptibility to |
| RS267607169 |
VDR
|
Health Risk |
Likely pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS267607170 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS267607171 |
VIPAS39
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS267607172 |
VIPAS39
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS267607173 |
VIPAS39
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS267607174 |
WDR35
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 2, Cranioectodermal dysplasia 2 |
| RS267607175 |
WDR35
|
Health Risk |
Likely pathogenic |
Cranioectodermal dysplasia 2, Cranioectodermal dysplasia 2 |
| RS267607176 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS267607177 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS267607178 |
WDR72
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta hypomaturation type 2A3, Amelogenesis imperfecta hypomaturation type 2A3 |
| RS267607179 |
XPNPEP3
|
Health Risk |
Pathogenic |
Nephronophthisis-like nephropathy 1, Nephronophthisis-like nephropathy 1 |
| RS267607180 |
YARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, lactic acidosis |
| RS267607181 |
ZMPSTE24
|
Health Risk |
Pathogenic |
Lethal tight skin contracture syndrome, Lethal tight skin contracture syndrome |
| RS267607182 |
ZNF513
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 58, Retinitis pigmentosa 58 |
| RS267607183 |
INF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS267607184 |
INSR
|
Health Risk |
Pathogenic |
Leprechaunism syndrome, Leprechaunism syndrome |
| RS267607185 |
INVS
|
Health Risk |
Pathogenic |
Infantile nephronophthisis, Nephronophthisis |
| RS267607186 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS267607187 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS267607188 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS267607189 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS267607190 |
ISCU
|
Health Risk |
Likely pathogenic |
Hereditary myopathy with lactic acidosis due to ISCU deficiency, Hereditary myopathy with lactic acidosis due to ISCU deficiency |
| RS267607191 |
IFT122
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS267607192 |
IFT122
|
Health Risk |
Likely pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS267607193 |
IFT122
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS267607194 |
KARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease recessive intermediate B, Charcot-Marie-Tooth disease recessive intermediate B |
| RS267607195 |
KCNA1
|
Health Risk |
Pathogenic |
Episodic ataxia type 1, Episodic ataxia type 1 |
| RS267607196 |
KCNJ11
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS267607198 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS267607199 |
KCTD7
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS267607200 |
KIF21A
|
Health Risk |
Pathogenic |
Fibrosis of extraocular muscles, congenital |
| RS267607201 |
KLF1
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia type 4, BLOOD GROUP--LUTHERAN INHIBITOR |
| RS267607203 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 1, Cerebral cavernous malformation |
| RS267607204 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 1, Cerebral cavernous malformation |
| RS267607205 |
KRT74
|
Health Risk |
Pathogenic |
Autosomal dominant wooly hair, Autosomal dominant wooly hair |
| RS267607206 |
L2HGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
L-2-hydroxyglutaric aciduria, L-2-hydroxyglutaric aciduria |
| RS267607209 |
LARGE1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 |
| RS267607210 |
LARGE1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 |
| RS267607211 |
LCAT
|
Health Risk |
Pathogenic |
LCAT deficiency, LCAT deficiency |
| RS267607213 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS267607216 |
LEMD3
|
Health Risk |
Pathogenic |
Dermatofibrosis lenticularis disseminata, Dermatofibrosis lenticularis disseminata |
| RS267607217 |
LEMD3
|
Health Risk |
Pathogenic |
Melorheostosis with osteopoikilosis, Dermatofibrosis lenticularis disseminata |
| RS267607218 |
LIPA
|
Health Risk |
Pathogenic |
Lysosomal acid lipase deficiency, Wolman disease |
| RS267607219 |
LIPH
|
Health Risk |
Pathogenic |
Woolly hair, autosomal recessive 2 |
| RS267607220 |
LRP4
|
Health Risk |
Pathogenic |
Cenani-Lenz syndactyly syndrome, Cenani-Lenz syndactyly syndrome |
| RS267607221 |
LRP4
|
Health Risk |
Pathogenic |
Cenani-Lenz syndactyly syndrome, Cenani-Lenz syndactyly syndrome |
| RS267607222 |
LRP4
|
Health Risk |
Likely pathogenic |
Cenani-Lenz syndactyly syndrome, Sclerosteosis 2 |
| RS267607223 |
LRP4
|
Health Risk |
Pathogenic |
Cenani-Lenz syndactyly syndrome, Cenani-Lenz syndactyly syndrome |
| RS267607224 |
LRP4
|
Health Risk |
Pathogenic |
Cenani-Lenz syndactyly syndrome, Cenani-Lenz syndactyly syndrome |
| RS267607225 |
DNAAF1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 13, Primary ciliary dyskinesia |
| RS267607226 |
DNAAF1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 13, Primary ciliary dyskinesia |
| RS267607227 |
DNAAF1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 13, Kartagener syndrome |
| RS267607228 |
LTBP4
|
Health Risk |
Pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS267607229 |
LTBP4
|
Health Risk |
Pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS267607230 |
MAP2K2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiofaciocutaneous syndrome 4, Cardio-facio-cutaneous syndrome |
| RS267607231 |
MC2R
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency 1, Glucocorticoid deficiency 1 |
| RS267607232 |
MED17
|
Health Risk |
Pathogenic |
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly, Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly |
| RS267607233 |
MEF2C
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS267607234 |
MEN1
|
Health Risk |
Pathogenic |
Angiofibroma, somatic |
| RS267607235 |
MFSD8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis |
| RS267607236 |
MLC1
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts |
| RS267607237 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome |
| RS267607238 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS267607239 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Inborn genetic diseases |
| RS267607240 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS267607241 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS267607243 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS267607247 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS267607257 |
MPV17
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome, Charcot-Marie-Tooth disease |